5 Most Shorted Stocks to Watch
Arcimoto, Inc. (NASDAQ:FUV) is a Eugene, Oregon-based electric vehicle company that manufactures two-wheel and three-wheel fun utility vehicles (FUV).
Heron Therapeutics Inc. (HRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 8,131,678 | $46,513 | 0.26% | |
| 2. | Tang Capital Management Kevin C. Tang | 3,720,000 | $21,278 | -53% | 4.25% |
| 3. | Partner Fund Management Christopher Medlock James | 3,512,348 | $20,091 | 0.75% | |
| 4. | Suvretta Capital Management Aaron Cowen | 2,869,048 | $16,411 | +16% | 0.5% |
| 5. | D E Shaw D. E. Shaw | 2,034,229 | $11,636 | +51% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.50 | 285,714 | Director | 5,799,810 | 2019-10-04 | Filing | |
| $17.50 | 4,571 | Officer, Director | 94,652 | 2019-10-03 | Filing | |
| $17.50 | 5,143 | Officer, Director | 18,143 | 2019-10-03 | Filing | |
| $17.55 | 3,000 | Director | 13,000 | 2019-05-22 | Filing | |
| $18.04 | 1,400 | Director | 1,400 | 2019-05-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.76 | 1,504 | Officer, Director | 10,872 | 2022-05-03 | Filing | |
| $9.73 | 300 | Director | 3,200 | 2021-12-21 | Filing | |
| $9.73 | 250 | Director | 2,840 | 2021-12-21 | Filing | |
| $12.31 | 300 | Director | 3,500 | 2021-09-21 | Filing | |
| $12.30 | 250 | Director | 3,090 | 2021-09-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,847,000 | $56,325,000 | 1.21% | |
| 2. | 257,585 | $1,473,386 | 0% | |
| 3. | 110,752 | $633,502 | 0% | |
| 4. | 12,923,369 | $73,922 | 0% | |
| 5. | 11,878,576 | $67,946 | 0.02% |
News See All
Short Sellers Are Targeting These 10 Stocks
In this article, we will be discussing 10 stocks that short sellers are targeting.
Short Sellers Were Right About These 10 Stocks
Short-sellers were the headliners of early 2021.
10 Growth Stocks Under $20 in Billionaire Ken Fisher's Portfolio
In this article, we discuss the 10 growth stocks under $20 in billionaire Ken Fisher's portfolio.
Is HRTX A Good Stock To Buy According To Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Heron Therapeutics Inc (HRTX): Hedge Funds Are Nibbling
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Heron Therapeutics Inc (HRTX) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here is What Hedge Funds Think About Heron Therapeutics Inc (HRTX)
In this article you are going to find out whether hedge funds think Heron Therapeutics Inc (NASDAQ:HRTX) is a good investment right now.
Do Hedge Funds Love Heron Therapeutics Inc (HRTX)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW.
Hedge Funds Cashed Out Of Heron Therapeutics Inc (HRTX) Too Early
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before last year's Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads...
Billionaire Hedge Funds
